Recombinant Human LCN2 Protein，His

LCN2 (Lipocalin-2) is a multifaceted protein involved in various physiological and pathological processes, including immune response, neuroprotection, and cancer progression. It is part of the lipocalin family, characterized by its ability to bind small hydrophobic molecules, such as fatty acids and hormones, which suggests a role in lipid transport and metabolism. Elevated levels of LCN2 have been associated with numerous conditions, including obesity, diabetes, and inflammatory diseases, indicating its potential as a biomarker for these disorders. In cancer research, LCN2 has been implicated in tumor progression and metastasis, often linked to promoting an inflammatory tumor microenvironment. Given its significant roles in these processes, the study of recombinant LCN2 protein has gained traction to elucidate its function further and explore its therapeutic potential. By employing recombinant DNA technology, researchers can produce LCN2 in substantial quantities, facilitating in vitro and in vivo studies. This allows for a better understanding of its interactions with receptors, downstream signaling pathways, and its role in various cellular contexts. Moreover, investigating LCN2's structure-function relationship could reveal novel mechanisms of action, paving the way for the development of targeted therapies in diseases where LCN2 is dysregulated. Overall, the study of LCN2 not only deepens our knowledge of its biological functions but also opens avenues for novel therapeutic interventions in metabolic and oncological diseases.